LINC 2022: ANEUFIX Novel Treatment for Type II Endoleak With Dr Hoksbergen

Просмотров: 154   |   Загружено: 2 год.
icon
Radcliffe Cardiology
icon
0
icon
Скачать
iconПодробнее о видео
Watch on Radcliffe Vascular:

Dr Arjan Hoksbergen (Amsterdam UMC Medical Center, NL) sits down to discuss the findings of a trial which studied the use of Aneufix ACP-T5 in treating patients with endoleaks following an EVAR procedure.

Discussion Points:
1. Study Rationale
2. Device Studied
3. Study Design and Patient Population
4. Key Findings
5. Conclusions
6. Further Study and Next Steps

Recorded remotely from Amsterdam, 2022.
Interviewer: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  LINC 2022: ANEUFIX Novel Treatment for Type II Endoleak With Dr Hoksbergen - RusLar.Me